The coronavirus disease 2019 (COVID-19) has been spreading globally for more than five months, since the World Health Organization officially and systematically began reporting the number of confirmed cases of COVID-19 in January 2020 [1]. Disease control involves multiple actions overtime to halt the spread of COVID-19. Scientists are devoted to investigating its pathology to develop treatments and vaccines [2, 3], and experts have noted that efficient medical solutions may not be available soon [4, 5]. Preventive actions (e.g., limiting international travels, maintaining personal hygiene, wearing masks, social distancing, and staying in lockdown) have therefore been a predominant theme in recent global scientific research to prevent further spreading of COVID-19. Governance represents the characteristics by which a country manages its authority [6]. It covers the process of selecting, monitoring, and replacing governments, the capability of effectively formulating and implementing sound policies, and the respect of citizens and the country for the institutions that manage their economic and social interactions [6]. Governance influences the design and implementation of health-related policies and services by mobilizing and coordinating stakeholders to realize common goals [7]. Good governance leads to good public health policies and actions [8], which may ultimately contribute to population health. To measure the level of governance across countries, the World Bank's Worldwide Governance Indicators project captures six dimensions of governance: perceptions of voice and accountability, political stability and absence of violence, government effectiveness, regulatory quality, rule of law, and control of corruption [6]. The perception-based data were used to reflect common views regarding governance outcomes from diverse survey respondents and experts in the surveys of individuals, households, firms, commercial businesses, non-governmental organizations, and public sectors [6]. These six World Bank's Governance Indicators have been used individually or as a whole to assess their associations with health outcomes in crosscountry comparison studies, such as countries with low regulatory quality showed 12 times higher maternal mortality risk is 12 times than